Bath & Body Works, Inc. (NYSE:BBWI) Shares Bought by American Century Companies Inc.

American Century Companies Inc. lifted its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 29.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 307,910 shares of the company's stock after acquiring an additional 70,418 shares during the quarter. American Century Companies Inc. owned 0.14% of Bath & Body Works worth $11,938,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Bath & Body Works by 32.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 52,784 shares of the company's stock worth $2,046,000 after purchasing an additional 12,964 shares during the period. Wellington Management Group LLP purchased a new stake in Bath & Body Works during the third quarter worth $8,129,000. Charles Schwab Investment Management Inc. boosted its position in Bath & Body Works by 13.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock valued at $66,088,000 after acquiring an additional 195,813 shares in the last quarter. iA Global Asset Management Inc. increased its holdings in shares of Bath & Body Works by 1,078.2% in the 3rd quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company's stock valued at $1,575,000 after acquiring an additional 45,144 shares during the period. Finally, Weiss Asset Management LP raised its position in shares of Bath & Body Works by 29.0% in the 3rd quarter. Weiss Asset Management LP now owns 377,969 shares of the company's stock worth $12,065,000 after acquiring an additional 84,873 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Bath & Body Works Price Performance

BBWI traded down $0.74 during trading on Friday, reaching $27.11. 9,960,931 shares of the company's stock were exchanged, compared to its average volume of 4,573,458. The company's fifty day simple moving average is $34.45 and its 200-day simple moving average is $34.10. The stock has a market capitalization of $5.81 billion, a P/E ratio of 6.61, a price-to-earnings-growth ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 1 year low of $25.41 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Equities analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works declared that its Board of Directors has initiated a share buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to purchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its stock is undervalued.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.95%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works's dividend payout ratio (DPR) is 21.98%.

Analyst Ratings Changes

BBWI has been the topic of several analyst reports. Argus reiterated a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. TD Cowen lifted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a research report on Thursday, December 12th. Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $40.00 to $48.00 in a research note on Friday, February 28th. Robert W. Baird raised their target price on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research note on Friday, February 28th. Finally, Raymond James reiterated an "outperform" rating and set a $46.00 price objective (up previously from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average price target of $45.06.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.